03/30 Morning Momentum Movers: PCOP, LNOP, HDTV, AVII, BCGI, VPHM
More News related to AVII
- AVI BioPharma (AVII) to Present Data for Duchenne Muscular Dystrophy Therapy at TREAT-NMD/NIH Conference
- AVI BioPharma, Inc. Presents Update on AVI-4658 at TREAT-NMD / NIH International Conference
- AVI BioPharma, Inc. to Present at Transformational Medical Technologies Initiative (TMTI) Industry Day
- AVI BioPharma (AVII) Misses Q3 Views by 1c
- AVI BioPharma Announces Third Quarter 2009 Financial Results & Corporate Highlights
More News related to BCGI
- Megasoft Completes Cash Tender Offer for Boston Communications (BCGI)
- StreetInsider.com Unusual 11 Mid-Day Movers 07/11/2007
- StreetInsider.com Pre-Open Movers 07/11
- Megasoft Acquires Boston Communications Group (BCGI) for $3.60/Share
- StreetInsider.com Unusual 11 Mid-Day Movers 06/11/2007
More News related to HDTV
- StreetInsider.com Unusual 11 Mid-Day Movers 06/12/2007
- Spatialight (HDTV) Sees Upside Action
- StreetInsider.com Unusual 11 Mid-Day Movers 04/18/2007
- The 52-Week Low Club
- SpatiaLight (HDTV) Receives 'Going Concern' From Independent Auditor
More News related to Momentum Movers
- Provident Financial (PROV) Commences $40M Stock Offering
- QKL Stores (QKLS) Completes 6 Million Share Offering
- Microvision (MVIS) Prices 3.3M Shares at $3/Share for Net Proceeds of ~$9.3M
- Yongye Int'l (YONG) Files $100M Mixed Securities Shelf
- SINA Corp. (SINA) Completes $180M Private Equity Financing with New-Wave
03/30 Morning Momentum Movers: Pharmacopeia Drug Discovery Inc. (NASDAQ: PCOP) 18.3% higher after company and GlaxoSmithKline Enter Into Drug Discovery and Development Alliance; LanOptics Ltd. (NASDAQ: LNOP) 18% higher on deal talk; Spatialight Inc. (NASDAQ: HDTV) 17% higher after saying it is successfully ramping up customer deliveries of T-3 Imagers; AVI Biopharma Inc. (NASDAQ: AVII) 13% higher on successul NEUGENE data for Influenza; Boston Communications Group Inc. (NASDAQ: BCGI) 12% higher on continued momentum; ViroPharma Inc. (NASDAQ: VPHM) 9.5% higher after positive preliminary results from a Phase 2 study with maribavir.
Related Categories
Momentum MoversSpecial Reports
Stocks Mentioned
-0.02
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
